Skip to main content

Don’t invest unless you’re prepared to lose all your money.
These are high-risk investments and you are unlikely to be protected if something goes wrong.
Take 2 mins to learn more.


Keep up to date with what is going on at Deepbridge, our investee companies and other exciting news.

Important Notice: Investments in unquoted companies carries high risks and investors could lose all funds invested. Investors should not invest if capital is required in the near term. No established market exists for the trading of shares in private companies, making it difficult to sell shares. The value of tax reliefs depend on personal circumstances and may be subject to change in the future. The availability of tax reliefs depends on the Company invested in maintaining its qualifying status. Past performance is not a guide to the future performance of an investment, and investors are encouraged to take independent legal, tax and financial advice before considering an investment.
Andrew Aldridge: Tax planning 'Top Trumps'

16th February 2022

Andrew Aldridge, Partner and Head of Marketing at Deepbridge, recently spoke with Professional Adviser to share his thoughts regarding the world of…

Full article
IbisVision Featured on BBC Scotland

14th February 2022

IbisVision, which is part of the Deepbridge Life Sciences EIS portfolio, has recently been featured on The Seven on BBC Scotland. This interview was…

Full article
Deepbridge Shortlisted for Deal of the Year Award

7th February 2022

  Deepbridge Capital has been shortlisted for the Deal of the Year (Transaction size below £2.5 million) Award at the upcoming 2022 Insider Media,…

Full article

2nd February 2022

  SmallSpark Space Systems, the award-winning rocket propulsion innovation company, has announced the closure of a significant overfunding of its…

Full article
Hy-genie's Hygeiene Tech Supported by Children's Hospital

1st February 2022

  Hy-genie, a portfolio company within the Deepbridge Life Sciences EIS fund, was a worthy winner of Business Cloud's MedTech 50 innovation ranking…

Full article
Deepbridge Capital Featured in GBI Magazine

28th January 2022

Deepbridge Capital has recently been featured in the first issue of GB Investments Magazine for 2022.  GBI Magazine spoke to several of the investee…

Full article
Aegiq Raises £1.8m For Quantum Networking Tech

27th January 2022

Aegiq, a University of Sheffield spin-out developing networking technology that's secure in the quantum computing age, has raised £1.8 million in…

Full article
UBS Partners With Fund Her North

26th January 2022

One of the world's largest global wealth managers, UBS, has partnered with Fund Her North, working to improve access to finance for female-led…

Full article
EIS Deployments in 2021/22 Tax Year

25th January 2022

The Deepbridge Technology Growth EIS and Deepbridge Life Sciences EIS usually deploy funds on a monthly basis, with numerous deployments expected…

Full article
Pathfinder Secures £8.5M Co-Funding

21st January 2022

Deepbridge has today (19 January 2022) announced that Pathfinder Medical, a portfolio company within the Deepbridge Life Sciences EIS fund has…

Full article

20th January 2022

One of Deepbridge's award-winning, leading European Cloud Software Technology Growth EIS Companies, Sardina Systems, has announced the opening of a…

Full article

19th January 2022

We are delighted to announce that we are the headline sponsor for Northcote's Obsession 2022 gourmet food festival.  Obsession is Northcote's annual…

Full article